DANA POINT, Calif. and NORCROSS, Ga., August 31—MediPurpose®, a leading medical device manufacturer and master distributor, today announced Jim Barley as its new vice president of engineering.
“The newly created position relieves a range of responsibilities from other executive leadership at MediPurpose,” said founder and CEO Patrick Yi. “It also leverages the diverse experience and skills Barley brings to the medical device company.”
A consultant to medical device companies for more than 20 years, Barley has established quality management system compliant to U.S. Food and Drug Administration regulation and international standards. He has also prepared 510(k) submissions to the FDA for capital equipment, disposables and instruments.
Prior to starting his consulting firm, Barley held several positions at the 3M Company in St. Paul, Minnesota, including product development supervisor, vice president of regulatory affairs and president of international ophthalmics.
Barley is a graduate of Lowell Technological Institute (Lowell, Massachusetts), with a bachelor’s degree in engineering, and Pepperdine University (Los Angeles), with a Master of Business Administration.
As MediPurpose continues to explore new avenues in medical product innovation, Yi said that Barley’s 20-plus years in product development, engineering and regulatory affairs will provide valuable counsel for all stages of medical product development.
“Jim is essentially wearing the hats of three vice presidents: engineering, quality assurance and regulatory affairs, and research and development,” said Yi. “Ultimately, we decided that ‘vice president of engineering’ would be the most concise and appropriate title for his very important roles.”
Barley shares Yi’s excitement for his new role at MediPurpose. “I find new medical product development to be very exciting,” said Barley. “When Patrick detailed the company's plan for expanding their medical product line following the recent launch of the babyLance™ infant heel incision device and its Wound Care Medical Products division, I wanted to help grow the company further.”
Barley will be based in Dana Point, California, in southern Orange County.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
IRVING, Texas and NORCROSS, Ga., August 11—MediPurpose® today announced that Novation has added the recently launched babyLance™ infant heel incision device to its medical product portfolio.
Novation, a leading healthcare supply contracting company, is now offering SurgiLance® safety lancets and babyLance™ infant heel incision devices to the more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC) and nearly 15,000 members of Provista, LLC.
“Our relationship with Novation dates back to 2005, and we are incredibly pleased that Novation continues to recognize the value of our medical products,” said MediPurpose Vice President Mark Stoppenbach. “Novation’s well-deserved reputation for consistently delivering high-quality medical products at competitive prices is well matched to our medical products’ reputations for safety, comfort and ease of use, and we look forward to a rewarding relationship.”
Since its launch in 1999, SurgiLance® safety lancets have become one of the world’s most popular needlestick solutions.
Introduced in July 2010 and specially designed for newborn caregivers, babyLance™ infant heel incision devices are MediPurpose’s latest offerings to the medical product market.
About Novation
Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 15,000 members of Provista, LLC.
Novation offers its customers contract development and management, supply-chain data and measurement, and industry knowledge and advocacy.
Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35.7 billion in 2008.
For more information on Novation, visit www.novationco.com.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
NORCROSS, Ga., Aug. 4—Manufactured by MediPurpose®, the SurgiLance® safety lancet was introduced to the United States medical product market in 2000. Since then, hundreds of millions SurgiLance® safety lancets have been sold to healthcare professionals and point-of-care (POC) diagnostic testing kit manufacturers.
Used to obtain blood samples from a patient’s finger, the SurgiLance® safety lancet is valued for its ease of use, comfort and safety. For A1C test kit manufacturers such as Bayer Healthcare whose popular A1CNow!® SELFCHECK at-home A1C system requires a blood sample to measure a patient’s A1C number, they also require a fingerstick solution that not only will be easy to use, comfortable and safe, but reliable as well.
“Although Bayer retails its A1C at-home test kits at very reasonable prices—usually well under $30—it’s perhaps a bit ironic that an OEM medical product that only costs a fraction of that amount can play such an important role in a kit’s functionality,” said Mark Stoppenbach, MediPurpose’s vice president of blood collection and analytics.
“When patients and healthcare professionals experience the ease, comfort and safety of our safety lancet, they are also experiencing its reliability, which are all hallmarks of the SurgiLance® safety lancet,” continued Stoppenbach. “Although patients might not be aware of our safety lancets’ low failure rates, diagnostic test manufacturers like Bayer certainly do—which is why we are flattered that they chose our OEM safety lancet for their A1C diagnostic kits.”
About the Bayer A1C SELFCHECK
Also called glycated hemoglobin, HbA1c, or hemoglobin A1C, A1C provides an indication of average blood glucose control for a 2–3-month period.
Bayer’s A1CNow® SELFCHECK is a simple way for patients to check their A1C level at home, between doctor visits.
According to Bayer, when used in conjunction with Bayer's CONTOUR® or Breeze®2 blood glucose meters, A1CNow® may help patients achieve tighter control in managing their diabetes, and may reduce long-term complications.
About Bayer Healthcare Diabetes Care
Bayer Diabetes Care, a worldwide leader in diabetes, supports customers in 100 countries.
Since 1941, Bayer has led the way in diabetes care product innovation with reagent tablets, the first portable blood glucose meter and test strips, the measurement of A1C (glycated hemoglobin) with the A1CNow+ monitor, and the first suite of blood glucose monitors with No Coding™ technology (CONTOUR® and BREEZE®2) that today offer people with diabetes an unparalleled choice in diabetes management systems.
Bayer Diabetes Care also offers comprehensive support to people with diabetes including education, tools and resources designed to simplify life with diabetes.
Bayer HealthCare Diabetes Care global headquarters is located in Tarrytown, New York, and operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer HealthCare group.
For more information, visit www.bayerdiabetes.com.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
HONG KONG, July 30—Ten years after introducing a medical device invention from Singapore to the U.S. medical products market that soon became the flagship of a thriving international enterprise, MediPurpose® CEO and founder Patrick Yi returns to Asia to share the story of his inspiring entrepreneurial journey.
 Patrick Yi |
Yi will be presenting “From an Asian Invention to Worldwide Commercialization: the MediPurpose Success Story” at the Hong Kong Institute of Patent Agents’ Commercializing Your Technology: Seminar & Panel Discussion on Monday, August 2.
“I’m truly honored to be invited to speak at HIPA on the success of our SurgiLance® safety lancet,” said Yi. “I hope that my story will inspire and educate aspiring innovators and entrepreneurs.”
Along with funding and licensing challenges and solutions, Yi’s presentation will review SurgiLance’s:
- Invention process
- Patent application
- Product development
- Commercialization
- Patent infringement
Born in Malaysia, Yi attended college and graduate school in Singapore before embarking on a highly successful career in business development and marketing prior to launching MediPurpose.
In 1998, SurgiLance® safety lancet inventor John Teo had reached a project-stopping obstacle faced by many early-stage medical device inventors. Although he had a prototype of an innovative safety lancet and had presented his medical device idea to venture capitalists (VC) and angel investors in Singapore, a lack of medical device funding had threatened to kill his project.
Through a focused, determined and collaborative effort of scoping, planning, financing and testing the medical device invention with Yi, the SurgiLance® safety lancet was successfully launched in 2000—and continues to be one of the best-selling safety lancets in the world.
Yi will deliver his presentation from 3:40–4:15 p.m. in the Hong Kong Science Park, Unit 307, 3/F, IF Development Centre, Shatin. For more information about the seminar, contact Katrina Yeung at 2629-6718 or visit http://www.hkstp.org.
Download a copy of Patrick Yi's presentation.
About the Hong Kong Institute of Patent Agents (HIPA)
HIPA is a non-profit organization established to promote and support Hong Kong as an international hub for the acquisition and commercialization of and respect for rights in technology, inventions, patents and other intellectual assets by acting as a professional governing body for training and recognizing patent practitioners in Hong Kong.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
NORCROSS, Ga., July 28—
MediPurpose® today announced the launch of its latest
safety medical product, the
babyLance™
heel incision device for infants.
A complement to the company’s vastly popular line of SurgiLance® safety lancets, babyLance™ is a safe, easy and effective solution for newborn heel incisions.
“We are very excited about this latest addition to our blood collection medical product portfolio,” said MediPurpose founder and CEO Patrick Yi. “It’s been 10 years since we launched our first product, the SurgiLance® safety lancet, and we are eager about offering this innovative new product to our customers.”
|
babyLance™ Newborn
|
|
babyLance™ Preemie
|
The babyLance™ will be available in two models:
Thoughtful, Innovative Features for End-Users
The new babyLance™ heel incision device line continues a tradition of thoughtful medical device innovation at MediPurpose. “As with our SurgiLance® safety lancet, the babyLance™ heel incision device was designed with innovative features that provide safety, comfort and ease of use,” said MediPurpose Vice President Mark Stoppenbach.
Among other features, the babyLance™ heel incision device provides:
- Ease of activation: Reduces trigger activation force, thereby significantly reducing the risk of bruising.
- Unique positioning design: Facilitates a stable and accurate placement against the targeted section of the infant’s heel while ensuring the procedure can be performed consistently and quickly.
- Compliance with regulatory and quality standards: Manufactured to the same regulatory and quality standards as the SurgiLance® safety lancet, the babyLance™ cutting blade’s swift pendulum action makes an incision that complies with the CLSI LA4-A5 established guidelines.
- Cost effectiveness: The babyLance™ heel incision device incorporates unique design characteristics that allow for the most cost-effective manufacturing process.
More information about babyLance™—including demonstration videos and free product sample requests—is available at www.medipurpose.com/babylance.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
210 New Leads and 210% Traffic Increase in Six Months
CAMBRIDGE, Mass. and NORCROSS, Ga., July 13—Barely six months after upgrading its Website to the HubSpot content management system, MediPurpose® has experienced significant boosts in its online performance, the subject of a case study published by HubSpot last week.
According to HubSpot, since January 2010, MediPurpose’s Website has:
- Increased organic traffic by 420 percent
- Accumulated more than 210 leads
- Achieved a 14-percent total conversion rate for seven landing pages
|
MediPurpose's organic Website traffic growth, January–May 2010.
|
“We selected MediPurpose to be featured as a case study because of the impressive results the company has seen in terms of attracting organic traffic, consistent blogging and lead generation,” said HubSpot’s Magdalena Georgieva. “What fascinated us about [their] marketing approach is the possibility to save from paid search and achieve company-wide engagement in the content production process. All around, a very inspirational story!”
The global medical device innovation and medical product distribution company migrated its Website to HubSpot’s content management system (CMS) as part of an initiative to attract new medical device inventors and innovators, as well as to market its current line of safety medical products and innovation and distribution services.
“As a company, we are fully embracing the concept of inbound marketing for marketing our medical products and services,” said MediPurpose founder and CEO Patrick Yi. “This means getting every employee at MediPurpose to become actively involved with blogging and social media, for example. HubSpot’s CMS and many of its integrated tools have helped us better fulfill our inbound marketing objectives and strategies.”
A Critical Need to Embrace New Media, Create Relevant Content
Although HubSpot’s CMS and tools have enabled MediPurpose to better interact with the online medical device community, the challenge to regularly produce relevant content—and to be active listeners to the community’s needs—will be essential to the company’s online and long-term success.
“There’s no question that we will need to always remain rock solid in traditional sales and marketing techniques—the kinds of irreplaceable one-on-one, personal business practices that have always driven the success of this company,” said MediPurpose Inbound Marketing and Communications Specialist Derek Rudnak. “But as a company that wants to leverage its reputation as a forward-thinking leader in all aspects of medical device innovation and distribution, it’s critical that we continue to embrace, adopt and advance our marketing and communications efforts with online and new media, which puts a high priority on content and interaction.”
Content must not only be relevant and frequent, but it must express a range of perspectives and experiences, said Rudnak. For instance, MediPurpose’s blog has already featured six of its employees, with plans for additional contributions from other staff and guest bloggers.
MediPurpose is also sharing its own experience in developing and commercializing medical devices through success stories and case studies.
In addition to blogs and case studies, MediPurpose recently announced the first installments of its online How To Guide for Medical Device Innovators, collaboratively produced by MediPurpose staff and contributing writers and editors from the medical device community.
But along with being optimized for maximum search engine visibility and shared with the medical device community via social media such as Twitter, Facebook and LinkedIn, the guide’s content has been—and will continue to be—influenced by the community.
“As contradictory as it may seem, the ability to produce effective content—which is a way to be heard—requires careful listening to the audience,” said Yi. “We are actively encouraging the medical device community to tell us what they need from us—or better yet, for them to share their own ideas, perspectives and expertise in our blogs, guides and other online content channels.
“By encouraging participation from our entire company—and those near and outside of it—we can strengthen our ability to connect and provide solutions.”
The complete case study and interview may be viewed at http://www.hubspot.com/customer-case-studies/bid/6124/Healthcare-Solutions-Company-Saves-from-PPC-Spending-with-HubSpot.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
NORCROSS, Ga., June 29—New medical device inventors and innovators in search of even the most basic instructions and advice about how to develop and launch a new medical product have often had to scour the Internet to gather resources of varying quality and relevance. But courtesy of the new How To Guide for Medical Device Innovators announced today by MediPurpose®, they now have a more convenient and comprehensive collection of helpful content relevant to their needs.
Divided into categories that span the myriad of requirements, considerations and obstacles faced by medical device innovators—including intellectual property, regulations and quality management systems—the guide is as much an outline of the “concept to commercialization” process as it is a directory for more advanced resources and solutions.
For example, “How to Get a Patent for a New Medical Device or Idea” introduces the need for medical device inventors to file an application with the U.S. Patent and Trademark Office, answers frequently asked questions (such as how long the process takes and how much it costs) and provides links to the USPTO and other relevant agencies and resources.
Widely known for its success in medical product manufacturing and distribution—such as with its popular line of SurgiLance® safety lancets—MediPurpose is developing the guide as a way to give something back to the medical device community and to strengthen it, said MediPurpose founder and CEO Patrick Yi.
Yi was quick to caution readers that the guide is not intended to present his company as an authority in every category or subject. Instead, it is a peek behind the curtain and introduces them to some essential concepts, processes and strategies for successfully moving a new medical device from concept to commercialization.
“For example, intellectual property and patents: We are not patent attorneys, nor do we offer patent legal services,” said Yi. “But, as experienced medical device innovators, we can use our knowledge of the general principles and processes involved in getting a medical device patent to help other innovators understand their options.”
Yi also said the guide will be continuously expanded, especially as MediPurpose continues to discover its readers’ educational and informational needs.
"Over the last few years, medical device innovators have been reaching out to us for help with refining and introducing their innovations, which influenced our decision to launch our new Innovation division last year," said Yi. "Since MediPurpose has the funding, proven methodology and global experience to assist innovators and inventors through the entire process, it became evident that it was a direction we needed to pursue."
“However, what we collectively know about the medical product development and commercialization processes is not widely available in a thoughtfully organized and well-written online format. By providing this information to the medical product innovation community, we hope to eliminate a lot of the problems that can discourage medical device innovation.”
Yi knows a thing or two about the challenges faced by newbies to the medical product industry. When he co-launched his medical device startup in Singapore in 1999, he was already a successful entrepreneur and businessperson in other business areas, but had virtually no experience with medical products. With the Internet still in its infancy and limited access to reliable resources in the medical device industry, Yi had to rely on his own business acumen, learning from his mistakes, and even a bit of luck before eventually building his company into a profitable and award-winning enterprise.
An Open Call for Contributors
“The success of the guide will ultimately be determined by how well the community engages with it—which includes its content creation and development,” said Yi. That is why he is actively encouraging the medical device community to:
- Suggest topics
- Recommend resources
- Contribute content
- Recommending experienced and knowledgeable writers
- Share the guide (e.g., referrals, social media)
The MediPurpose® How to Guide for Medical Product Innovators is located at http://www.medipurpose.com/how-to-guide-for-medical-device-innovators.
For more information or to make suggestions or contributions, visit http://www.medipurpose.com/contact-united-states/.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
Agreement is First for MediPurpose’s New Wound Care Division
ALEXANDRIA, Egypt and NORCROSS, Ga., June 22—MediPurpose®, a medical device innovation and medical product distribution company, today announced that it has signed an exclusive agreement to distribute advanced wound care products from Egypt-based OEM Pharmaplast.
The milestone agreement is the foundation for MediPurpose’s recently launched Wound Care division. For Pharmaplast, it enables access to an expanded market for its products within the Americas while continuing to expand their worldwide presence.
“We are very pleased to announce our exclusive partnership with Pharmaplast,” said MediPurpose COO and President Randy Prather, who oversees the Wound Care division. “Their quality and breadth of product line of advanced wound care products is the ideal foundation for our Wound Care division.”
The new Wound Care division—and the subsequent agreement with Pharmaplast—spotlights MediPurpose’s attention on new business development to expand medical product lines that complement their award-winning medical product distribution services and logistics capabilities.
“Our distribution services capability was a key advantage that MediPurpose was able to offer that cemented the relationship with our new OEM partner,” said Prather. “MediPurpose's goal was to provide a quality, comprehensive advanced wound care line that would afford substantial profit opportunities for our existing and new distribution partners who service this market. Pharmaplast provided us the opportunity to meet and exceed those original goals."
“Additionally, with the launch of this new division, we are very excited about the opportunities to expand the division’s product capabilities by partnering with additional wound care products manufacturers that offer complementary products in the Americas and abroad.”
MediPurpose founder and CEO Patrick Yi added, "It is our responsibility to ensure that all our new medical product lines achieve the same superior product quality and customer service as our current SurgiLance® safety lancet product line. After an exhaustive evaluation, I am confident that our customers will receive the same standard of service from Pharmaplast."
About Pharmaplast
Started in 1985 by three pharmacists, Pharmaplast engages in the manufacture of advanced wound care and immobilization products.
Today, Pharmaplast is a shareholding company with five factories in Egypt that employ 700 employees. All factories are ISO 9001 certified, all products bear the CE mark and most of the products are FDA registered.
Pharmaplast believes that consistent innovation and quality assurance is the key to its survival, and thus invests to generate new products that help medical professionals to provide quality patient care with maximum cost-efficiency.
For more information about Pharmaplast, please visit www.pharmaplast-online.com.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
GREENVILLE, S.C. and NORCROSS, Ga., June 16—MediPurpose®, a medical device innovation and medical product distribution company, today announced that its popular SurgiLance® safety lancets have been selected for inclusion in the ID Biological Systems’ Dried Biological Specimen Collection Kit.
ID Biological Systems provides a complete, turnkey kitting service solution for customers requiring the collection of dried biological specimens. Each collection kit utilizes the new Grade 226 filter media for the collection of blood, urine and oral fluid.
Customers of ID Biological Systems are now using this complete service for their collections and analysis of HIV, A1c, lipid profiles, DNA and IgG allergy testing.
“The SurgiLance® safety lancet provides our customers with a high quality, easy-to-use, and affordable device for fingerstick collections,” said ID Biological Systems President Brad Davin. “Customers who sampled the SurgiLance® lancet have switched to this device for all fingerstick blood sample collections.”
MediPurpose’s vice president of blood collection and analytics, Mark Stoppenbach, said, “We’re excited about the opportunity to work with ID Biological Systems on this and future projects. It’s always a pleasure to work with diagnostic kit manufacturers, especially those that truly recognize the value and quality of our safety lancets.”
About ID Biological Systems
ID Biological Systems was formed with the sole purpose of producing newborn screening, DNA and other custom medical collection devices utilizing filter paper. ID Biological Systems has brought a completely new and validated filter paper to the market.
ID Grade 226 is a highly absorbent and uniform filter paper specially selected for newborn screening. It complies with all Centers for Disease Control (CDC) standards for newborn screening and is FDA-approved for use (registered as a Class II IVD Medical Device).
The president and owner of ID Biological has more than 30 years of experience in newborn screening, with a focus on the design and production of medical collection devices for dried biological specimens.
For more information about ID Biological Systems, please visit www.id-biological.com.
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
Randy Prather to Head New Division While Mark Stoppenbach becomes Head of Blood Collection and Analytics
NORCROSS, Ga., June 9—MediPurpose®, a medical device innovation and medical product distribution company, today announced that MediPurpose’s president and COO Randy Prather will head its new Wound Care division.
|
|
Randy Prather
|
"With the launch of this new division, we are very excited about the opportunity to expand the division’s product capabilities by partnering with additional manufacturers that offer complementary products in the United States and abroad," said MediPurpose founder and CEO Patrick Yi.
MediPurpose today also announced that MediPurpose Vice President Mark Stoppenbach will head its Blood Collection and Analytics division. Stoppenbach will supervise the manufacture, distribution and sales of MediPurpose’s expanding blood collection and analysis product lines.
Yi said that Stoppenbach’s new role will ensure adequate attention for the company’s products and customers as it continues a trend of exploring new avenues that leverage the company’s experience in medical product manufacturing, distribution and sales.
Late last year, the company rolled out two new divisions, Innovation and Distribution, intended for new medical device inventors and existing medical product manufacturers seeking entrance or expansion into medical device markets.
In addition to Prather and Stoppenbach’s new divisional responsibilities, Yi has assumed responsibility for the New Business Development and Operations division, previously managed by Prather.
“As a small, innovative company, we have the flexibility to reorganize our resources to meet new business challenges,” said Yi. “As we take on new medical product categories, we will create new divisions as required, and staff will be challenged with new responsibilities.”
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices the United States and Europe.
Known for its innovation of the SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.